Search for: "WYETH, INC." Results 641 - 660 of 877
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
7 Nov 2008, 3:42 am
Sandoz, Inc (Patent Docs) (PATracer) Boniva (Ibandronic acid) – US: Hoffman La Roche files third patent infringement lawsuit against Orchid over generic Boniva (GenericsWeb) Carbatrol (Carbamazepine) – US: Federal Judge grants summary judgment of noninfringement to Corepharma in Carbatrol patent dispute with Shire Laboratories (Law360) Effexor (Venlafaxine) – US: Wyeth settles with fourth drug company, Anchen Pharmaceuticals, over generic Effexor… [read post]
8 Feb 2011, 10:51 pm by Marie Louise
(FDA Law Blog) US: Another academic with solutions to problems that don’t exist (Patent Docs) US: Syngenta files for declaratory judgment of invalidity and non-infringement of Bayer’s patents based on its development of GM crops containing HPPD gene (Patent Docs) US: District Court New Jersey: Loss of market share to infringing competitor during six year reexamination warrants denial of stay: Wyeth et al v Abbott (Docket Report) US: District Court New Jersey: Court precludes… [read post]
15 Dec 2009, 11:32 pm by Dr. Shezad Malik
In comparison, Pfizer Inc., parent of Wyeth, the maker of diet-drug combination fen-phen, has had to set aside about $21 billion to resolve about 200,000 personal-injury claims over that medicine. [read post]
27 Apr 2010, 10:58 pm
(The SPC Blog) EU: Originator drug companies hit by European ruling: C-62/09 Association of the British Pharmaceutical Industry (Managing Intellectual Property) EU: EPO – Convention on Biological Diversity and the exception to patentability for inventions which are contrary to ‘ordre public’ or morality (EPLAW) India: Patent office releases details on pharmaceutical product patents granted in last 3 years (Generic Pharmaceuticals and IP) (Spicy IP) Kenya: High Court suspends… [read post]
29 Jun 2011, 5:00 am by Bexis
Bayer Cropscience, Inc., ___ S.W.3d ___, 2011 WL 2184317, at *10-13 (Tenn. [read post]
19 Jun 2007, 9:06 am
Caterpillar, Inc., 480 F.3d 202, 209 (3d Cir. 2007); Pedraza v. [read post]
23 Mar 2007, 11:35 am
., Beckman Coulter, Bridgestone Americas, Bristol-Myers Squibb, Cargill Incorporated, Caterpillar, Cephalon, CheckFree, Corning, Dow Chemical, Eastman Chemical, Electronics for Imaging, E.I. du Pont (DuPont), Eli Lilly, ExxonMobil, General Electric, Genzyme, GlaxoSmithKline, Henkel Corporation, Hoffman-La Roche, Johnson & Johnson, Merck, Millennium Pharmaceuticals, Monsanto, Motorola, Novartis, Patent Café.com Inc., Pfizer, Procter & Gamble, Sangamo… [read post]
15 Feb 2011, 5:26 pm by Marie Louise
General Pharma backs calls for extension of TRIPS deadline for least-developed countries (IP Watch) Medicines Patent Pool in talks with Big Pharma (Spicy IP) Protect Pharma sells patent portfolio to Grunenthal GmbH (GenericsWeb) Australia: Federal Court upholds TGA decision to refuse access to documents relating to applications to list generics on the ARTG (IP Whiteboard) EU clarifies statement on ARVs (GenericsWeb) Mexico: Pharma patents in Mexico: an assessment of the current position (IP tango)… [read post]
28 Jun 2016, 9:02 am by Dean Freeman
Wyeth Inc., in ruling in 2008 that the maker of a drug called Reglan could be liable to a plaintiff who used the generic version.The state supreme court declined to hear the Conte case, so this will be the first time that court will consider a challenge like this. [read post]
29 Mar 2007, 4:46 am
Wyeth Labs., Inc., 161 N.J. 1, 25 (1999). [read post]